semaglutide pfizer Novo sues Lilly, alleging 'misleading' advertising of obesity drugs Novo Nordisk sued Eli Lilly

Pancreatic Inflammation & Potential Pancreatic Damage While GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro) are widely used and carry established warnings for acute pancreatitis, extensive large-scale studies show the overall absolute risk remains very low, and long-term data indicates they do not increase the lifetime risk of pancreatic damage for most patients Pancreatitis is a known risk of GLP-1 drugs, but long-term consequences are still being studied

Partial NAMPT inhibition in combination with other concurrent axis could improve efficacy decreasing toxicity

Whether cleaner attribution is more important than broader category coverage

Injections circumvent absorption issues but require clinic visits

Several sources state Swiss product or Swiss dermatological technology.